A study in Diabetic Medicine showed that adding GLP-1 receptor agonists was associated with the best rate of attaining A1C goals among type 2 diabetes patients with baseline A1C levels between 7% and 7.9%, while adding insulin led to the lowest attainment rate, compared with those whose treatment was not intensified. Researchers used a cohort of 7,389 patients and found the best goal attainment rate among those whose baseline A1C levels were between 8% and 8.9% was seen in those who received another oral antidiabetes drug, while the worst rate was seen in those whose treatment was not intensified.
Research looks at effect of treatment intensification on A1C outcomes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.